Anxiety: A Neurological Perspective
Anxiety is not a personality trait. It is a measurable pattern of dysregulated brain circuitry—amygdala hyperactivation, prefrontal cortex suppression, and HPA axis overdrive that produces real neurological and metabolic consequences. When the wiring is the problem, the wiring is what needs to be evaluated.
Anxiety Is a Circuit Problem, Not a Stress Problem
The distinction matters clinically. Stress is a normal physiological response to threat—a time-limited activation of the sympathetic nervous system that resolves when the stimulus passes. Anxiety disorders involve a failure of that resolution. The threat-detection system stays on. The amygdala continues firing. The prefrontal cortex, which should modulate and ultimately suppress that signal, cannot override it.
LeDoux (2015, Anxious: Using the Brain to Understand and Treat Fear and Anxiety) reframed anxiety as a disorder of defensive survival circuitry—not an emotion problem, but a circuit problem. The amygdala evaluates sensory input for potential threat and triggers downstream autonomic and hormonal responses. Under normal conditions, the medial prefrontal cortex provides top-down inhibition, essentially telling the amygdala that the threat has passed. In anxiety disorders, this regulatory mechanism fails. The amygdala runs unchecked, and the body pays the price.
McEwen (2007, Physiology & Behavior) documented the concept of allostatic overload—the cumulative physiological cost of chronic stress system activation. When the hypothalamic-pituitary-adrenal axis remains hyperactivated for weeks or months, cortisol levels stay elevated. Chronic cortisol exposure damages hippocampal neurons, impairs memory consolidation, suppresses BDNF production, disrupts sleep architecture, and drives systemic inflammation. The anxiety itself becomes a source of brain injury.
This is what patients describe when they say anxiety has gotten worse over time. It is not imagination. It is neurodegeneration driven by the very circuits that are supposed to protect them.
The Metabolic Machinery Behind Anxiety
Anxiety is not purely a neurotransmitter imbalance that can be corrected with a single medication. The metabolic substrate beneath the symptoms is often far more complex. Boyle et al. (2017, JAMA Psychiatry) demonstrated that anxiety disorders share significant genetic and metabolic overlap with other neurological conditions, suggesting that the same cellular deficits—mitochondrial dysfunction, oxidative stress, micronutrient depletion—contribute to multiple diagnostic categories.
Magnesium deficiency alone can produce anxiety symptoms that are clinically indistinguishable from generalized anxiety disorder. Boyle et al. (2017, Nutrients) reviewed evidence that magnesium modulates NMDA receptor function, HPA axis activity, and GABAergic neurotransmission. When intracellular magnesium is low, excitatory glutamate signaling increases, the stress axis becomes hyperresponsive, and inhibitory GABA tone decreases. The result is a neurological state primed for anxiety—caused not by psychology but by a mineral deficit.
Thyroid dysfunction, B-vitamin deficiency (particularly B6, B12, and folate), vitamin D insufficiency, and iron deficiency all produce or amplify anxiety through distinct neurological mechanisms. A patient taking an SSRI for anxiety caused by subclinical hypothyroidism will not respond adequately to the medication, because the medication does not address the problem. Standard psychiatric intake does not typically evaluate these metabolic pathways. Our workup does.
Our Diagnostic Approach
Every anxiety evaluation at The Neurogenesis Project begins with the question: what is driving this patient’s anxiety at the cellular and circuit level? We do not start with a prescription. We start with data.
Dr. Orr conducts a comprehensive neurological examination and orders targeted lab panels measuring cortisol with diurnal rhythm assessment, thyroid function (full panel including antibodies), RBC magnesium, B-vitamin status, vitamin D, inflammatory markers (hs-CRP, homocysteine), and markers of mitochondrial function and oxidative stress. These panels reveal the specific metabolic deficits sustaining each patient’s symptoms.
Advanced neuroimaging is used when clinically indicated to evaluate structural and functional integrity of the prefrontal cortex, amygdala, and hippocampal formations. Cognitive testing with normative comparison quantifies the executive function and attentional deficits that anxiety produces—deficits that patients experience as brain fog, difficulty concentrating, and impaired decision-making.
Dr. Drew Edwards evaluates the behavioral and cognitive consequences of chronic anxiety and builds a NeuroCoaching protocol that translates diagnostic findings into practical strategies for autonomic regulation, stress management, and cognitive recovery. The clinical picture that emerges from this combined evaluation is far more precise than a symptom checklist and a prescription.
How We Treat This
Treatment is built from your diagnostic findings. Each intervention targets a specific dimension of the neurological and metabolic dysfunction sustaining your anxiety.
NAD+ IV Therapy
Restores the coenzyme depleted by chronic HPA axis activation. Supports mitochondrial ATP production in prefrontal and limbic neurons, enabling the brain to sustain the energy-intensive work of regulating anxiety circuits.
Glutathione IV Therapy
The brain’s primary antioxidant defense. Chronic cortisol elevation drives oxidative stress that damages neurons in the hippocampus and prefrontal cortex. Intravenous glutathione directly reduces this oxidative burden and supports neuronal recovery.
NeuroCoaching
Dr. Edwards builds a structured program that translates neurological findings into daily strategies for autonomic regulation, cognitive restructuring, and stress management grounded in the neuroscience of your specific anxiety pattern.
Brain Health Lab Panels
Comprehensive metabolic testing that identifies the correctable deficiencies—magnesium, B vitamins, thyroid, vitamin D, cortisol rhythm—that are sustaining your anxiety at the cellular level.
Myers’ Cocktail IV
Delivers magnesium, B vitamins, and vitamin C directly into the bloodstream at concentrations that oral supplementation cannot achieve. Addresses the specific micronutrient deficiencies that amplify anxiety through NMDA receptor and GABAergic pathways.
Advanced Neuroimaging
When clinically indicated, brain MRI with advanced sequences evaluates structural integrity of the amygdala, hippocampus, and prefrontal cortex—the regions most affected by chronic anxiety and cortisol exposure.
Related Treatments
Depression: When Medication Isn’t Enough
Anxiety and depression share overlapping neural circuits and metabolic pathways. When both are present, addressing the neurological substrate often improves both conditions simultaneously.
Insomnia & Sleep Disorders
Chronic anxiety disrupts sleep architecture through sustained autonomic arousal. Sleep deprivation, in turn, worsens prefrontal function and amplifies amygdala reactivity—a bidirectional cycle that treatment must interrupt.
Brain Fog Treatment
The cognitive impairment that accompanies chronic anxiety—difficulty concentrating, impaired working memory, slowed processing speed—is a measurable neurological deficit, not a subjective complaint.
Frequently Asked Questions
How is a neurological evaluation for anxiety different from a psychiatric one?+
What lab work do you run for anxiety patients?+
Can anxiety actually cause brain changes visible on imaging?+
Will I need to stop my current psychiatric medications to be treated here?+
How does NAD+ therapy help with anxiety?+
How long does the evaluation and treatment program take?+
Anxiety Has a Neurology. We Evaluate It.
If your anxiety has not responded adequately to medication, the problem may not be the medication. It may be that nobody has looked at what your brain actually needs to regulate itself. Dr. Orr and Dr. Edwards at The Neurogenesis Project are accepting new patients in St. Marys, Georgia.